Cardiovascular Risk With and Without Antihypertensive Drug Treatment in the Japanese General Population: Participant-Level Meta-Analysis

To evaluate the cardiovascular mortality risk in association with blood pressure level among people with and without antihypertensive treatment, we performed the participant-level meta-analysis that included 39 705 Japanese from 6 cohorts (58.4% women; mean age, 60.1 years; 20.4% treated). Multivariable-adjusted Cox models were used to analyze the risk of cardiovascular mortality and its subtypes among 6 blood pressure levels according to recent guidelines, optimal to Grade 3 hypertension, and the usage of antihypertensive medication at baseline. During median 10.0 years of follow-up, there were 2032 cardiovascular deaths (5.1 per 1000 person-years), of which 410 deaths were coronary heart disease, 371 were heart failure, and 903 deaths were stroke. Treated participants had significantly higher risk for cardiovascular mortality (hazard ratios, 1.50; 95% confidence intervals, 1.36–1.66), coronary heart disease (hazard ratios, 1.53; confidence intervals, 1.23–1.90), heart failure (hazard ratios, 1.39; confidence intervals, 1.09–1.76), and stroke (hazard ratios, 1.48; confidence intervals, 1.28–1.72) compared with untreated people. Among untreated participants, the risks increased linearly with an increment of blood pressure category (P⩽0.011). The risk increments per blood pressure category were higher in young participants (<60 years; 22% to 79%) than those in old people (≥60 years; 7% to 15%) with significant interaction for total cardiovascular, heart failure, and stroke mortality (P⩽0.026). Among treated participants, the significant linear association was also observed for cardiovascular mortality (P=0.0003), whereas no stepwise increase in stroke death was observed (P=0.19). The risks of cardiovascular mortality were ≈1.5-fold high in participants under antihypertensive medication. More attention should be paid to the residual cardiovascular risks in treated patients.

[1]  V. Basevi.  Standards of Medical Care in Diabetes—2013 , 2012, Diabetes Care.

[2]  E. O'Brien.  First Thomas Pickering Memorial Lecture * : Ambulatory Blood Pressure Measurement is Essential for the Management of Hypertension , 2012, Journal of clinical hypertension.

[3]  A. Tamakoshi,et al.  Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in Japan , 2012, Journal of the American Heart Association.

[4]  T. Ohkubo,et al.  Blood pressure categories and long-term risk of cardiovascular disease according to age group in Japanese men and women , 2012, Hypertension Research.

[5]  F. Irie,et al.  Influence of Smoking Combined with Another Risk Factor on the Risk of Mortality from Coronary Heart Disease and Stroke: Pooled Analysis of 10 Japanese Cohort Studies , 2012, Cerebrovascular Diseases.

[6]  M. Izumi,et al.  Advantages and limitations of antihypertensive treatment for stroke risk in a general population: the Akita Stroke Registry , 2011, Acta cardiologica.

[7]  Sabine Steiner,et al.  Time trends in cardiovascular and all-cause mortality in the ‘old’ and ‘new’ European Union countries , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  K. Asayama,et al.  Stroke risk in treated hypertension based on home blood pressure: the Ohasama study. , 2010, American journal of hypertension.

[9]  T. Ogihara,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) , 2009, Hypertension Research.

[10]  A. Zanchetti.  Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced? , 2009, Journal of hypertension.

[11]  T. Ogihara,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2 , 2009, Hypertension Research.

[12]  M. Inoue,et al.  Blood pressure and the risk of stroke, cardiovascular disease, and all-cause mortality among Japanese: the JPHC Study. , 2009, American journal of hypertension.

[13]  K. Asayama,et al.  Stroke risk and antihypertensive drug treatment in the general population: the Japan arteriosclerosis longitudinal study , 2009, Journal of hypertension.

[14]  H. Ibsen.  Antihypertensive treatment and risk of cardiovascular complications: is the cure worse than the disease? , 2009, Journal of hypertension.

[15]  H. Ueshima,et al.  Relation of Blood Pressure and All-Cause Mortality in 180 000 Japanese Participants: Pooled Analysis of 13 Cohort Studies , 2008, Hypertension.

[16]  J. Tuomilehto,et al.  Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study , 2008, Blood pressure.

[17]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[18]  H. Ueshima,et al.  Medical costs of patients with hypertension and/or diabetes: a 10-year follow-up study of National Health Insurance in Shiga, Japan , 2006, Journal of hypertension.

[19]  Shinichi Kuriyama,et al.  Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. , 2006, JAMA.

[20]  E. Oda.  Incidence of Type 2 Diabetes in Individuals With Central Obesity in a Rural Japanese Population: The Tanno and Sobetssu Study , 2006, Diabetes Care.

[21]  F. Irie,et al.  Age-Specific Relationship between Blood Pressure and the Risk of Total and Cardiovascular Mortality in Japanese Men and Women , 2005, Hypertension Research.

[22]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[23]  K. Miura,et al.  Relationship of alcohol consumption to 7-year blood pressure change in Japanese men , 2005, Journal of hypertension.

[24]  L. Wilhelmsen,et al.  Stroke and coronary heart disease in treated hypertension – a prospective cohort study over three decades , 2005, Journal of internal medicine.

[25]  G. Berglund,et al.  Blood Pressure Control and Risk of Stroke: A Population-Based Prospective Cohort Study , 2005, Stroke.

[26]  G. Berglund,et al.  Risk Factors for Stroke in Subjects With Normal Blood Pressure: A Prospective Cohort Study , 2005, Stroke.

[27]  M. Yamada,et al.  Relationship between HbA1c and mortality in a Japanese population , 2005, Diabetologia.

[28]  G. Thorgeirsson,et al.  Risk profiles and prognosis of treated and untreated hypertensive men and women in a population-based longitudinal study The Reykjavik Study , 2004, Journal of Human Hypertension.

[29]  H. Ueshima,et al.  Cigarette Smoking as a Risk Factor for Stroke Death in Japan NIPPON DATA80 , 2004, Stroke.

[30]  P. Elliott,et al.  Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. , 2004, American heart journal.

[31]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[32]  L. Guize,et al.  Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population , 2003, Journal of hypertension.

[33]  K. Miura,et al.  High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study , 2003, Stroke.

[34]  M. Fujishima,et al.  Validity of the JNC VI recommendations for the management of hypertension in a general population of Japanese elderly: the Hisayama study. , 2003, Archives of internal medicine.

[35]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[36]  A. Tamakoshi,et al.  Perceived Mental Stress and Mortality From Cardiovascular Disease Among Japanese Men and Women: The Japan Collaborative Cohort Study for Evaluation of Cancer Risk Sponsored by Monbusho (JACC Study) , 2002, Circulation.

[37]  Jan A Staessen,et al.  Cardiovascular protection and blood pressure reduction: a meta-analysis , 2001, The Lancet.

[38]  A. Folsom,et al.  Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. , 2000, International journal of epidemiology.

[39]  T. Vetter,et al.  Epidemiology: Study Design and Data Analysis , 2000 .

[40]  T. Hedner,et al.  Survival in treated hypertension: follow up study after two decades , 1998, BMJ.

[41]  N. Nishi,et al.  Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. , 1997, Stroke.

[42]  M. Parmar,et al.  Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.

[43]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[44]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[45]  T. Chalmers,et al.  Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.

[46]  M. Litwin,et al.  Guidelines for the Management of Hypertension , 2015 .

[47]  Yutaka Imai,et al.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) , 2014, Hypertension Research.

[48]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[49]  H. Ueshima,et al.  The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population. , 2006, Atherosclerosis.

[50]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .